FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agustín Escobedo

Research Profile

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Catalina Falo; Abelardo Moreno; Mar Varela; Belen Lloveras; Agnès Figueras; Agustín Escobedo
HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy.
Edurne Arriola; Abelardo Moreno; Mar Varela; Jose Ma Serra; Catalina Falo; Enrique Benito; Agustín Escobedo
Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer.
Catalina Falo; Abelardo Moreno; Enrique Benito; Belen Lloveras; Mar Varela; Jose Ma Serra; Luis Prieto; Diego Azpeitia; Agustín Escobedo
Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agustín Escobedo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Catalina Falo; Abelardo Moreno; Mar Varela; Belen Lloveras; Agnès Figueras; Agustín Escobedo
HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy.
Journal of cancer research and clinical oncology 2007;133(7):423-9.
2006: Edurne Arriola; Abelardo Moreno; Mar Varela; Jose Ma Serra; Catalina Falo; Enrique Benito; Agustín Escobedo
Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(17):2954-60.
2005: Catalina Falo; Abelardo Moreno; Enrique Benito; Belen Lloveras; Mar Varela; Jose Ma Serra; Luis Prieto; Diego Azpeitia; Agustín Escobedo
Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma.
Cancer 2005;103(4):657-63.
2004: M Cortés Romera; M T Bajen; A Fernández León; Enrique Benito; Diego Azpeitia; Luis Prieto; Abelardo Moreno; Yvonne Ricart; Agustín Escobedo; Josep Martín-Comín
[Sentinel lymph node (SN) detection in patients with breast cancer. Influence of tumor size and age of the patient].
Revista española de medicina nuclear 2004;23(1):3-8.
2003: Catalina Falo; Abelardo Moreno; Belen Lloveras; Agnès Figueras; Mar Varela; Agustín Escobedo
Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas.
American journal of clinical oncology 2003;26(5):465-70.
2002: A Fernandez; Agustín Escobedo; Enrique Benito; Diego Azpeitia; A Guma; Luis Prieto; Abelardo Moreno; J Martin-Comin
Sentinel node localization in patients with non-palpable breast cancer.
Nuclear medicine communications 2002;23(12):1165-9.
2002: Abelardo Moreno; Agustín Escobedo; Enrique Benito; Jose Ma Serra; Anna Gumà; Francisco Riu
Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome.
Breast cancer research and treatment 2002;75(2):119-25.
2001: Abelardo Moreno; Agnès Figueras; Belen Lloveras; Agustín Escobedo; E Griera; Angels Sierra; Angels Fabra
Apoptosis in ductal carcinoma in situ of the breast.
The breast journal 2001;7(4):245-8.
2001: A Fernández; M Cortés; Enrique Benito; Diego Azpeitia; Luis Prieto; Abelardo Moreno; Yvonne Ricart; J Mora; Agustín Escobedo; Josep Martín-Comín
Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme.
Nuclear medicine communications 2001;22(4):361-6.
2001: Olga Méndez; S Máñas; Angels Fabra; Agustín Escobedo; Abelardo Moreno; Angels Sierra
Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas.
Breast cancer research and treatment 2001;65(2):171-7.
2000: Angels Sierra; Xavier Castellsagué; Agustín Escobedo; Belen Lloveras; M García-Ramirez; Abelardo Moreno; Angels Fabra
Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
International journal of cancer. Journal international du cancer 2000;89(2):142-7.
1999: Angels Sierra; X Castellsague; Agustín Escobedo; Abelardo Moreno; T Drudis; Angels Fabra
Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas.
Breast cancer research and treatment 1999;54(1):39-45.
1999: A Muñoz; Agustín Escobedo; Enrique Benito; Diego Azpeitia; M Recaj; Yvonne Ricart; Josep Martín-Comín
[Radioisotopic localization of the sentinel lymph node in breast cancer. Preliminary results].
Revista española de medicina nuclear 1999;18(1):37-42.
1998: Angels Sierra; Xavier Castellsagué; T Coll; S Mañas; Agustín Escobedo; Abelardo Moreno; Angels Fabra
Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
International journal of cancer. Journal international du cancer 1998;79(2):103-10.
1997: Abelardo Moreno; Belen Lloveras; Agnès Figueras; Agustín Escobedo; J M Ramon; Angels Sierra; Angels Fabra
Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(11):1088-92.
1996: Angels Sierra; X Castellsagué; S Tórtola; Agustín Escobedo; B Lloveras; Miguel A Peinado; Abelardo Moreno; Angels Fabra
Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1887-94.
1996: Teresa Cabrera; M Angustias Fernandez; A Sierra; A Garrido; A Herruzo; Agustín Escobedo; Angels Fabra; Federico Garrido
High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Human immunology 1996;50(2):127-34.